Matthew Scotch

 (Last 10 publications out of 109 total)

1. Vargas J*, Bermudez-Rivera B*, Block I, Shaffer G, Estrada L, Dadd T, Dickerson T, Curtis C, Woods C, Driver EM, Halden RU, Varsani A, Scotch M, Faleye TOC. Canine Parvovirus and Vaccine-Origin Feline Panleukopenia Virus in Wastewater, Arizona, USA: July 2022-June 2023. Microorganisms. 2025 Sep 11;13(9):2124. doi: 10.3390/microorganisms13092124. 
2. Yeh KB, Bahnfleth WP, Bradforda E, Cardona C, Coleman KK, Hudson PJ, Dadonaite B, Hutchins RJ, Maresso A, MacIntyre CR, Scotch M. Three things we can do now to reduce the risk of avian influenza spillovers. Proc Natl Acad Sci U S A. 2025 Aug 5;122(31):e2503565122.
3. Negrete AU, Nelson S, Scotch M, Faleye TOC. Influenza B virus from respiratory samples of individuals with influenza-like illness in a university campus in Arizona USA, in February 2025. Microbiol Resour Announc. 2025 Jul 7:e0034425.
4. Strike W*, Faleye TOC, Lubega B, Rockward A, Torabi S, Noble A, Banadaki MD, Keck J, Mugerwa H, Scotch M, Berry S. Implementing wastewater-based epidemiology for long-read metagenomic sequencing of antimicrobial resistance in Kampala, Uganda. Microorganisms. 2025 May 28;13(6):1240.
5. Wang X*, Sevendal AT, Kamalakkannan A, Stelzer-Braid S, Kim KW, Scotch M, Walker GJ, Rawlinson WD. Influenza epidemiology and co-infections within New South Wales-based multicentre health districts between 2018 and 2023. Pathology. 2025 Apr 22:S0031-3025(25)00158-8. doi: 10.1016/j.pathol.2025.02.009.
6. O'Connor K, Weissenbacher D, Elyaderani A, Lautenbach E, Scotch M, Gonzalez-Hernandez G. Patient-related metadata reported in sequencing studies of SARS-CoV-2: protocol for a scoping review and bibliometric analysis. JMIR Res Protoc. 2025 Apr 22;14:e58567.
7. Chung JR, Price AM, Zimmerman RK, Moehling Geffel K, House SL, Curley T, Wernli KJ, Phillips CH, Martin ET, Vaughn IA, Murugan V, Scotch M, Saade EA, Faryar KA, Gaglani M, Ramm JD, Williams OL, Walter EB, Kirby M, Keong LM, Kondor R, Ellington SR, Flannery B; US Flu VE Network Investigators. Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season. Clin Infect Dis. 2025 Jan 6:ciae658.
8. Faleye TOC, Skidmore P*, Elyaderani A*, Adhikari S, Kaiser N*, Smith A*, Yanez A, Perleberg T, Driver EM, Halden RU, Varsani A, Scotch M. Adenovirus 41 diversity in Arizona (USA) using wastewater-based epidemiology, long-range PCR, and pathogen sequencing between October 2019 and March 2020. Epidemiol Infect. 2024 Nov 18;152:e142.
9. Bermudez-Rivera B*, Hampton B*, Wheeler C*, Vargas J*, Swaminathan S, Driver EM, Halden RU, Varsani A, Scotch M, Faleye TOC. Nine rhizobium phage genomes recovered from wastewater in Tempe, AZ, October 2019-March 2020. Microbiol Resour Announc. 2024 Oct 10;13(10):e0068024.

10. Wang X*, Walker G, Kim KW, Stelzer-Braid S, Scotch M, Rawlinson WD. The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID-19 restrictions during the 2022 season. J Med Virol. 2024 Sep;96(9):e29922.

    *Student authors